Back to OCUPOcuphire Pharma, Inc. (OCUP)View full pipeline
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist
Phase 3Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Mesopic Vision
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Phentolamine Ophthalmic Solution 0.75%Phase 3
Mydriasis
Phentolamine Opthalmic Solution 0.75%Phase 3
Presbyopia
0.75% phentolamine ophthalmic solutionPhase 3
Presbyopia
Phentolamine Ophthalmic Solution VehiclePhase 3
Mydriasis
Phentolamine Mesylate Ophthalmic Solution 1%Phase 2
Open Angle Glaucoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts